US FDA approves Stemline Therapeutics’ rare blood disease treatment
Elzonris will be commercially available in early 2019
Author
Merck, Pfizer to end late-stage ovarian cancer treatment study
The setbacks come at a time when the drug is competing against other immunotherapy cancer drugs such as Merck & Co’s Keytruda,…
‘Our primary focus is to reach out to customers who have more specific needs’
Bio-Techne empowers researchers in life sciences and clinical diagnostics by providing high-quality reagents, instruments, custom…
Aurobindo receives US FDA approval for Vecuronium Bromide injection
The product will be launched in Q4FY19
70th Indian Pharmaceutical Congress concludes
Discussions were held on how in the coming months the sector will see stricter implementation of quality standards and increased…
Lupin in partnership with AbbVie
To develop and commercialise a novel oncology drug to treat haematological cancers
Experts discuss IPR and its role in industry’s growth trajectory at IPC 2018
Stress on the need to bring innovation in the IPR framework
Pharma captains share success stories at 70th IPC
Inspire students to follow their dreams and withstand any challenges in their quest to success
Experts discuss strategies to tackle AMR at IPC 2018
Advocate that AMR needs a one health approach for both humans and animals, at both the national and global levels
KC Chatterjee Memorial Lecture held at IPC 2018
Discussions were held on regulations of medical devices and role of state regulatory authorities